Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The objective of this study is to determine whether the administration of N-acetylcysteine (NAC) improves oxidative stress. To determine this, the study will assess the impact of oral treatment on the balance between reduced and oxidized form of glutathione in erythrocytes of peripheral blood.
Epistemonikos ID: d4cc6909aee4064b69d5eb82c18395208d133342
First added on: May 12, 2024